MEIRAGTX HOLDINGS PLC

MGTX NASDAQ
21.31
+0.06
+0.28%
盘后: 21.31 0 0.00% 16:36 08/20 EDT
开盘
20.92
昨收
21.25
最高
21.61
最低
20.84
成交量
6.68万
成交均量(3M)
17.90万
52周最高
30.23
52周最低
8.53
换手率
0.25%
市值
5.79亿
分时
5日
1月
3月
1年
5年

相关股票

微牛行情栏目提供MEIRAGTX HOLDINGS PLC MGTX股票价格,MEIRAGTX HOLDINGS PLC股票实时行情,公司简介,财报信息,股本结构等,掌握美港股行情走势,开盘价,收盘价,总市值,换手率,市盈率,收益率等数据,及时把握美股港股投资机会。

公司介绍

MeiraGTx Holdings plc is a clinical-stage therapy company. The Company develops gene therapy treatments for a range of inherited and acquired disorders. It is focused on developing therapies for ocular diseases, including rare inherited blindness, as well as Xerostomia, radiation treatment for head and neck cancers and neurodegenerative diseases, such as amyothrophic lateral sclerosis (ALS). It is also developing transformative technology to enable the use of small molecules to turn gene therapy product candidates on and off. It is focused on three areas of unmet medical needs, including inherited retinal diseases, severe forms of xerostomia and neurodegenerative diseases. Its product candidates include AAV-CNGB3, AAV-CNGA3, AAV-RPGR, AAV-RPE65, A006, AAV-AQP1 and AAV-UPF1.
展开 >

最近浏览

名称
价格
涨跌幅